Era Past Earnings Performance
Past criteria checks 1/6
Era's earnings have been declining at an average annual rate of -20.8%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 2.8% per year. Era's return on equity is 4.2%, and it has net margins of 3.5%.
Key information
-20.8%
Earnings growth rate
-23.4%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 2.8% |
| Return on equity | 4.2% |
| Net Margin | 3.5% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Era makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 6,719 | 232 | 858 | 233 |
| 30 Jun 24 | 6,980 | 318 | 852 | 240 |
| 31 Mar 24 | 7,119 | 301 | 947 | 246 |
| 31 Dec 23 | 7,471 | 363 | 946 | 248 |
| 30 Sep 23 | 7,636 | 291 | 1,032 | 228 |
| 30 Jun 23 | 7,852 | 186 | 1,124 | 230 |
| 31 Mar 23 | 7,865 | 123 | 1,097 | 234 |
| 01 Jan 23 | 7,978 | 78 | 1,111 | 241 |
| 30 Sep 22 | 8,375 | 282 | 942 | 273 |
| 30 Jun 22 | 8,700 | 388 | 842 | 285 |
| 31 Mar 22 | 9,009 | 534 | 741 | 283 |
| 31 Dec 21 | 8,881 | 577 | 740 | 282 |
| 30 Sep 21 | 8,653 | 592 | 794 | 287 |
| 30 Jun 21 | 8,184 | 746 | 765 | 276 |
| 31 Mar 21 | 7,770 | 807 | 724 | 264 |
| 31 Dec 20 | 7,036 | 770 | 645 | 239 |
| 30 Sep 20 | 6,638 | 724 | 763 | 216 |
| 30 Jun 20 | 6,289 | 592 | 725 | 204 |
| 31 Mar 20 | 5,949 | 493 | 712 | 195 |
| 31 Dec 19 | 6,291 | 514 | 776 | 204 |
| 30 Sep 19 | 6,041 | 410 | 648 | 202 |
| 30 Jun 19 | 5,836 | 360 | 665 | 188 |
| 31 Mar 19 | 5,616 | 295 | 709 | 173 |
| 31 Dec 18 | 5,354 | 245 | 713 | 163 |
| 30 Sep 18 | 5,070 | 225 | 687 | 161 |
| 30 Jun 18 | 4,927 | 213 | 646 | 218 |
| 31 Mar 18 | 4,668 | 194 | 649 | 180 |
| 31 Dec 17 | 4,570 | 193 | 654 | 145 |
| 30 Sep 17 | 4,413 | 129 | 686 | 97 |
| 30 Jun 17 | 4,154 | 156 | 755 | 0 |
| 31 Mar 17 | 3,917 | 195 | 721 | 0 |
| 31 Dec 16 | 3,767 | 215 | 714 | 0 |
| 30 Sep 16 | 3,621 | 284 | 702 | 0 |
| 30 Jun 16 | 3,556 | 269 | 669 | 0 |
| 31 Mar 16 | 3,564 | 266 | 667 | 0 |
| 31 Dec 15 | 3,533 | 259 | 647 | 0 |
| 30 Sep 15 | 3,530 | 248 | 631 | 0 |
| 30 Jun 15 | 3,480 | 219 | 603 | 0 |
| 31 Mar 15 | 3,534 | 193 | 594 | 0 |
| 31 Dec 14 | 3,455 | 193 | 554 | 0 |
| 30 Sep 14 | 3,237 | 179 | 494 | 0 |
| 30 Jun 14 | 3,137 | 210 | 466 | 0 |
| 31 Mar 14 | 2,969 | 225 | 440 | 0 |
| 31 Dec 13 | 2,918 | 243 | 424 | 0 |
Quality Earnings: 002641 has high quality earnings.
Growing Profit Margin: 002641's current net profit margins (3.5%) are lower than last year (3.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002641's earnings have declined by 20.8% per year over the past 5 years.
Accelerating Growth: 002641's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 002641 had negative earnings growth (-20.2%) over the past year, making it difficult to compare to the Chemicals industry average (-5.3%).
Return on Equity
High ROE: 002641's Return on Equity (4.2%) is considered low.